ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 172 filers reported holding ANTARES PHARMA INC in Q1 2021. The put-call ratio across all filers is 0.48 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $632,000 | -44.9% | 154,063 | -52.1% | 0.00% | -100.0% |
Q4 2021 | $1,147,000 | -33.2% | 321,489 | -31.8% | 0.00% | 0.0% |
Q3 2021 | $1,717,000 | -44.4% | 471,419 | -33.4% | 0.00% | 0.0% |
Q2 2021 | $3,086,000 | +41.2% | 707,716 | +33.1% | 0.00% | 0.0% |
Q1 2021 | $2,186,000 | +208.3% | 531,689 | +199.3% | 0.00% | – |
Q4 2020 | $709,000 | +28.7% | 177,629 | -13.0% | 0.00% | – |
Q3 2020 | $551,000 | +14.3% | 204,081 | +16.6% | 0.00% | – |
Q2 2020 | $482,000 | -22.6% | 175,021 | -33.7% | 0.00% | -100.0% |
Q1 2020 | $623,000 | -83.5% | 263,923 | -67.3% | 0.00% | -50.0% |
Q4 2019 | $3,787,000 | +1224.1% | 806,141 | +832.5% | 0.00% | – |
Q3 2019 | $286,000 | -74.6% | 86,446 | -74.8% | 0.00% | -100.0% |
Q2 2019 | $1,126,000 | -63.8% | 342,828 | -66.6% | 0.00% | -50.0% |
Q1 2019 | $3,111,000 | +513.6% | 1,027,481 | +449.9% | 0.00% | – |
Q4 2018 | $507,000 | -75.6% | 186,851 | -69.8% | 0.00% | -100.0% |
Q3 2018 | $2,075,000 | +59.2% | 618,173 | +22.3% | 0.00% | – |
Q2 2018 | $1,303,000 | +217.8% | 505,551 | +170.6% | 0.00% | – |
Q1 2018 | $410,000 | -35.4% | 186,839 | -41.6% | 0.00% | – |
Q4 2017 | $635,000 | -73.5% | 319,943 | -56.7% | 0.00% | -100.0% |
Q3 2017 | $2,395,000 | -25.9% | 739,608 | -26.4% | 0.00% | 0.0% |
Q2 2017 | $3,233,000 | +722.6% | 1,004,627 | +625.6% | 0.00% | – |
Q1 2017 | $393,000 | +62.4% | 138,459 | -40.0% | 0.00% | – |
Q2 2016 | $242,000 | +65.8% | 230,825 | +36.6% | 0.00% | – |
Q1 2016 | $146,000 | -36.8% | 168,977 | -12.1% | 0.00% | – |
Q4 2015 | $231,000 | +42.6% | 192,346 | +100.8% | 0.00% | – |
Q3 2015 | $162,000 | -10.5% | 95,766 | +9.8% | 0.00% | – |
Q2 2015 | $181,000 | +34.1% | 87,185 | +74.3% | 0.00% | – |
Q1 2015 | $135,000 | -38.4% | 50,023 | -41.4% | 0.00% | – |
Q4 2014 | $219,000 | +14.1% | 85,432 | -19.7% | 0.00% | – |
Q3 2014 | $192,000 | +1.1% | 106,337 | +48.4% | 0.00% | – |
Q2 2014 | $190,000 | -34.9% | 71,642 | -14.4% | 0.00% | – |
Q1 2014 | $292,000 | +24.8% | 83,717 | +59.6% | 0.00% | – |
Q4 2013 | $234,000 | -65.4% | 52,462 | -68.6% | 0.00% | – |
Q3 2013 | $677,000 | – | 166,902 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Stonepine Capital Management, LLC | 3,130,192 | $12,834,000 | 5.32% |
Velan Capital Investment Management LP | 1,346,971 | $5,523,000 | 5.12% |
FIRST WILSHIRE SECURITIES MANAGEMENT INC | 2,799,953 | $11,480,000 | 4.03% |
Sargent Investment Group, LLC | 3,663,275 | $15,019,000 | 3.78% |
PERKINS CAPITAL MANAGEMENT INC | 481,483 | $1,974,000 | 1.62% |
Rubric Capital Management LP | 10,900,000 | $44,690,000 | 1.62% |
ORACLE INVESTMENT MANAGEMENT INC | 1,720,000 | $7,052,000 | 1.39% |
Long Focus Capital Management, LLC | 540,000 | $2,214,000 | 0.28% |
OBERWEIS ASSET MANAGEMENT INC/ | 344,200 | $1,411,000 | 0.28% |
FIRETHORN WEALTH PARTNERS, LLC | 84,069 | $345,000 | 0.26% |